Correlation Between Strategic Allocation: and Health Biotchnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Strategic Allocation: and Health Biotchnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Strategic Allocation: and Health Biotchnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Strategic Allocation Servative and Health Biotchnology Portfolio, you can compare the effects of market volatilities on Strategic Allocation: and Health Biotchnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Strategic Allocation: with a short position of Health Biotchnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Strategic Allocation: and Health Biotchnology.

Diversification Opportunities for Strategic Allocation: and Health Biotchnology

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Strategic and Health is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Strategic Allocation Servative and Health Biotchnology Portfolio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Health Biotchnology and Strategic Allocation: is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Strategic Allocation Servative are associated (or correlated) with Health Biotchnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Health Biotchnology has no effect on the direction of Strategic Allocation: i.e., Strategic Allocation: and Health Biotchnology go up and down completely randomly.

Pair Corralation between Strategic Allocation: and Health Biotchnology

Assuming the 90 days horizon Strategic Allocation Servative is expected to generate 0.5 times more return on investment than Health Biotchnology. However, Strategic Allocation Servative is 2.0 times less risky than Health Biotchnology. It trades about 0.16 of its potential returns per unit of risk. Health Biotchnology Portfolio is currently generating about 0.06 per unit of risk. If you would invest  539.00  in Strategic Allocation Servative on September 3, 2024 and sell it today you would earn a total of  46.00  from holding Strategic Allocation Servative or generate 8.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Strategic Allocation Servative  vs.  Health Biotchnology Portfolio

 Performance 
       Timeline  
Strategic Allocation: 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Strategic Allocation Servative are ranked lower than 13 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Strategic Allocation: is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Health Biotchnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Health Biotchnology Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Health Biotchnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Strategic Allocation: and Health Biotchnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Strategic Allocation: and Health Biotchnology

The main advantage of trading using opposite Strategic Allocation: and Health Biotchnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Strategic Allocation: position performs unexpectedly, Health Biotchnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Biotchnology will offset losses from the drop in Health Biotchnology's long position.
The idea behind Strategic Allocation Servative and Health Biotchnology Portfolio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data